Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This clinical trial studies the use of omega-3 fatty acid supplementation in preventing aromatase inhibitor-induced toxicity in patients with stage I-III breast cancer. An omega-3 supplementation may help relieve moderate to severe bone pain and improve joint symptoms caused by aromatase inhibitor-induced arthralgias.
Epistemonikos ID: de2ef586b4e5aa859e9f2bb81ceab060b7ef172a
First added on: May 17, 2024